1. Synthesis and Evaluation of Novel 2-Oxo-1,2-dihydro-3-quinolinecarboxamide Derivatives as Potent and Selective Serotonin 5-HT4 Receptor Agonists
- Author
-
Chika Ito, Masaji Suzuki, Hajime Asanuma, Sadakazu Yokomori, Yoshihiko Isobe, Makoto Muramatsu, Yutaka Ohuchi, and Toshie Kaneko
- Subjects
Male ,Agonist ,medicine.drug_class ,Drug Evaluation, Preclinical ,Chemical synthesis ,Dogs ,Drug Discovery ,medicine ,Animals ,Structure–activity relationship ,Serotonin 5-HT4 Receptor Agonists ,Receptor ,Gastric emptying ,Chemistry ,Spectrum Analysis ,General Chemistry ,General Medicine ,Amides ,Serotonin Receptor Agonists ,Biochemistry ,Receptors, Serotonin ,Quinolines ,Female ,Receptors, Serotonin, 5-HT4 ,Serotonin ,Gastrointestinal Motility ,Endogenous agonist - Abstract
A series of 8'-substituted N-(endo-8-azabicyclo[3.2.1]oct-3-yl)-1-isopropyl-2-oxo-1, 2-dihydro-3-quinolinecarboxamides were synthesized. The 5-HT4 receptor agonistic activity was evaluated using the isolated guinea pig ileum preparation. Of the compounds synthesized, N-(endo-8-(3-hydroxypropyl)-8-azabicyclo[3.2.1]oct-3-yl)-1-isopropyl-2-oxo-1, 2-dihydro-3-quinolinecarboxamide (15a, TS-951) exhibited the most potent serotonin 5-HT4 receptor agonistic activity. This compound had a high affinity for the serotonin 5-HT4 receptor althought it had no affinities for other broad spectrum receptors. Furthermore, it remarkably enhanced gastrointestinal motility in conscious fed dogs without unfavorable effects that non-selective serotonin 5-HT4 receptor agonist has. TS-951 may be useful in improving gastrointestinal dysfunction.
- Published
- 2001